BEAM
Price
$21.66
Change
-$0.21 (-0.96%)
Updated
Nov 13 closing price
Capitalization
2.2B
109 days until earnings call
Intraday BUY SELL Signals
OCGN
Price
$1.24
Change
-$0.10 (-7.46%)
Updated
Nov 13 closing price
Capitalization
387.28M
133 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BEAM vs OCGN

Header iconBEAM vs OCGN Comparison
Open Charts BEAM vs OCGNBanner chart's image
Beam Therapeutics
Price$21.66
Change-$0.21 (-0.96%)
Volume$3.65M
Capitalization2.2B
Ocugen
Price$1.24
Change-$0.10 (-7.46%)
Volume$4.44M
Capitalization387.28M
BEAM vs OCGN Comparison Chart in %
View a ticker or compare two or three
VS
BEAM vs. OCGN commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and OCGN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (BEAM: $21.66 vs. OCGN: $1.24)
Brand notoriety: BEAM and OCGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 145% vs. OCGN: 78%
Market capitalization -- BEAM: $2.2B vs. OCGN: $387.28M
BEAM [@Biotechnology] is valued at $2.2B. OCGN’s [@Biotechnology] market capitalization is $387.28M. The market cap for tickers in the [@Biotechnology] industry ranges from $110.25B to $0. The average market capitalization across the [@Biotechnology] industry is $2.11B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green whileOCGN’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • OCGN’s FA Score: 0 green, 5 red.
According to our system of comparison, BEAM is a better buy in the long-term than OCGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 4 TA indicator(s) are bullish while OCGN’s TA Score has 4 bullish TA indicator(s).

  • BEAM’s TA Score: 4 bullish, 7 bearish.
  • OCGN’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, OCGN is a better buy in the short-term than BEAM.

Price Growth

BEAM (@Biotechnology) experienced а -6.44% price change this week, while OCGN (@Biotechnology) price change was -10.14% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.47%. For the same industry, the average monthly price growth was -3.12%, and the average quarterly price growth was +62.00%.

Reported Earning Dates

BEAM is expected to report earnings on Mar 03, 2026.

OCGN is expected to report earnings on Mar 27, 2026.

Industries' Descriptions

@Biotechnology (+1.47% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($2.2B) has a higher market cap than OCGN($387M). OCGN YTD gains are higher at: 66.460 vs. BEAM (-12.661). OCGN has higher annual earnings (EBITDA): -52.34M vs. BEAM (-414.33M). BEAM has more cash in the bank: 1.15B vs. OCGN (27M). OCGN has less debt than BEAM: OCGN (32.8M) vs BEAM (155M). BEAM has higher revenues than OCGN: BEAM (60.3M) vs OCGN (4.75M).
BEAMOCGNBEAM / OCGN
Capitalization2.2B387M568%
EBITDA-414.33M-52.34M792%
Gain YTD-12.66166.460-19%
P/E RatioN/AN/A-
Revenue60.3M4.75M1,268%
Total Cash1.15B27M4,259%
Total Debt155M32.8M473%
FUNDAMENTALS RATINGS
OCGN: Fundamental Ratings
OCGN
OUTLOOK RATING
1..100
53
VALUATION
overvalued / fair valued / undervalued
1..100
90
Overvalued
PROFIT vs RISK RATING
1..100
93
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
43
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
20

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMOCGN
RSI
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 3 days ago
73%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 3 days ago
83%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 3 days ago
80%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 3 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 3 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 3 days ago
88%
Advances
ODDS (%)
Bullish Trend 9 days ago
78%
Bullish Trend 22 days ago
81%
Declines
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 4 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 3 days ago
82%
Aroon
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
BEAM
Daily Signal:
Gain/Loss:
OCGN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ARDEX6.15-0.03
-0.49%
AMG River Road Dividend All Cap Value N
VGWAX35.10-0.19
-0.54%
Vanguard Global Wellington Admiral
MALOX20.79-0.22
-1.05%
BlackRock Global Allocation Instl
ECTMX17.20-0.23
-1.32%
Eaton Vance Dividend Builder C
IBSAX13.39-0.24
-1.76%
VY® Baron Growth A

BEAM and

Correlation & Price change

A.I.dvisor indicates that over the last year, BEAM has been closely correlated with CRSP. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if BEAM jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
-0.96%
CRSP - BEAM
70%
Closely correlated
-2.07%
RXRX - BEAM
62%
Loosely correlated
-6.88%
NTLA - BEAM
61%
Loosely correlated
-8.64%
PRME - BEAM
61%
Loosely correlated
-6.20%
AXON - BEAM
57%
Loosely correlated
-2.15%
More

OCGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, OCGN has been loosely correlated with RAIN. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if OCGN jumps, then RAIN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OCGN
1D Price
Change %
OCGN100%
+0.75%
RAIN - OCGN
53%
Loosely correlated
-3.49%
ARRY - OCGN
47%
Loosely correlated
-8.69%
AXON - OCGN
46%
Loosely correlated
-0.47%
IPSC - OCGN
44%
Loosely correlated
N/A
BEAM - OCGN
41%
Loosely correlated
-2.71%
More